Literature DB >> 19678791

Fighting tuberculosis: old drugs, new formulations.

Paolo Blasi1, Aurélie Schoubben, Stefano Giovagnoli, Carlo Rossi, Maurizio Ricci.   

Abstract

This review reports the state of the art on innovative drug delivery strategies designed for antitubercular chemotherapeutics. The introduction contains the fundamental biological background concerning tuberculosis and a review of the current antitubercular therapy, and is followed by a critical report of the micrometric and nanometric particulate systems designed and investigated to improve tuberculosis chemotherapy.

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19678791     DOI： 10.1517/17425240903130577

Source DB:  PubMed          Journal:  Expert Opin Drug Deliv        ISSN： 1742-5247            Impact factor:   6.648


  6 in total

1.  Development and Characterization of a Dry Powder Formulation for Anti-Tuberculosis Drug Spectinamide 1599.

Authors:  Ian E Stewart; Pradeep B Lukka; Jiuyu Liu; Bernd Meibohm; Mercedes Gonzalez-Juarrero; Miriam S Braunstein; Richard E Lee; Anthony J Hickey
Journal:  Pharm Res       Date:  2019-07-18       Impact factor: 4.200

2.  An isoniazid analogue promotes Mycobacterium tuberculosis-nanoparticle interactions and enhances bacterial killing by macrophages.

Authors:  Tatiany J de Faria; Mariane Roman; Nicole M de Souza; Rodrigo De Vecchi; João Vitor de Assis; Ana Lúcia Gomes dos Santos; Ivan H Bechtold; Nathalie Winter; Maurilio José Soares; Luciano Paulino Silva; Mauro V De Almeida; André Báfica
Journal:  Antimicrob Agents Chemother       Date:  2012-02-13       Impact factor: 5.191

3.  Appraisal of fluoroquinolone-loaded carubinose-linked hybrid nanoparticles for glycotargeting to alveolar macrophages.

Authors:  Priyanka Maurya; Ravi Saklani; Samipta Singh; Raquibun Nisha; Ravi Raj Pal; Nidhi Mishra; Priya Singh; Abhiram Kumar; Manish K Chourasia; Shubhini A Saraf
Journal:  Drug Deliv Transl Res       Date:  2021-09-03       Impact factor: 4.617

4.  Mycobacterium tuberculosis phosphoribosylpyrophosphate synthetase: biochemical features of a crucial enzyme for mycobacterial cell wall biosynthesis.

Authors:  Anna P Lucarelli; Silvia Buroni; Maria R Pasca; Menico Rizzi; Andrea Cavagnino; Giovanna Valentini; Giovanna Riccardi; Laurent R Chiarelli
Journal:  PLoS One       Date:  2010-11-15       Impact factor: 3.240

5.  Antitubercular Nanocarrier Combination Therapy: Formulation Strategies and in Vitro Efficacy for Rifampicin and SQ641.

Authors:  Suzanne M D'Addio; Venkata M Reddy; Ying Liu; Patrick J Sinko; Leo Einck; Robert K Prud'homme
Journal:  Mol Pharm       Date:  2015-04-17       Impact factor: 4.939

6.  Critical physicochemical and biological attributes of nanoemulsions for pulmonary delivery of rifampicin by nebulization technique in tuberculosis treatment.

Authors:  Kifayatullah Shah; Lai Wah Chan; Tin Wui Wong
Journal:  Drug Deliv       Date:  2017-11       Impact factor: 6.419
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.